Feed CBDD
Summary
12 / 100 · Bulios Score
Valuation 29Growth 0Profitability 2Quality 21Debt 2Stability 19
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- Revenue fell by 45% a year over the last 3 years.
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- It passes only 0 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
20202021202220232024
Diluted EPS (USD)
20202021202220232024
Revenue fell by 45% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Cash and short-term investments $8.52K
Debt $979.7K
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.